NCT05442749
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05442749
Title Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer (PARPi-PANC)
Acronym PARPi-PANC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Georges François Leclerc Dijon 21079 France Details
Centre Hospitalier Universitaire Grenoble Alpes Grenoble 38043 France Details
Centre Léon Bérard Lyon 69373 France Details
Centre Hospitalier Lyon Sud Pierre-Bénite 69495 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field